Skip to content

Investigation of the effect of test food intake on fatigue reduction after exercise load

Investigation of the effect of test food intake on fatigue reduction after exercise load - Investigation of the effect of test food intake on fatigue reduction after exercise load

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000059841
Enrollment
40
Registered
2025-11-20
Start date
2025-11-27
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy male adults

Interventions

Consumption of test food for 8 weeks Consumption of placebo food for 8 weeks

Sponsors

Metagen, Inc.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (1) At informed consent, male subjects aged more than or equal to 20, and less than 65 years old. (2) Subjects who habitually exercise once or twice a week (exercise of 5 METs or more for 30 minutes or more, excluding resistance training). (3) Subjects who can continue their exercise habits from before study participation during the study period. (4) Subjects who can consume coffee daily. (5) Subjects who can show their understanding of the study procedure and agreement with participating in the study by informed consent prior to the study.

Exclusion criteria

Exclusion criteria: (1) Subjects who are unable to discontinue consumption of foods for specified health uses, foods with function claims, health foods that may affect the study (fatigue-reducing effect, intestinal regulation, etc.) from the time consent is obtained. (2) Subjects who are unable to discontinue consumption of supplements (including powder, tablets, capsules, and other forms distinct from ordinary foodstuffs, taken for nutritional or functional purposes regardless of ingredients or functionality) from the time consent is obtained. (3) Subjects who have taken drugs (antibiotics, intestinal regulators, laxatives, etc.) that would affect the study one month prior to the pre-test, or those who plan to take them during the study. (4) Subjects with a tendency for constipation (defecation frequency of 5 times or less per week) or a tendency for diarrhea (more than half of weekly defecations are mushy or watery stools) at the background survey. (5) Subjects with a history of appendectomy. (6) Subjects who have undergone surgery that may affect the study (colonoscopy, removal of gallstones or gall bladder, gastric bypass surgery, bariatric surgery, etc.) within 6 months prior to obtaining consent. (7) Subjects who are expected to undergo a major change in their family, work, or other living environment (e.g., relocation, transfer, etc.) during the study. (8) Subjects with extremely irregular eating habits or lifestyle rhythms. (9) Subjects whose roommates plan to participate in the study. (10) Subjects who have smoked within the past year. (11) Heavy alcohol drinkers. (12) Subjects with a history of serious diseases of the heart, liver, kidneys, digestive organs, etc. (13) Subjects allergic to medicines and foods. (Due to character limitation, the following will be listed in the "Others" section)

Design outcomes

Primary

MeasureTime frame
Fatigue VAS

Secondary

MeasureTime frame
1. Defecation status (presence or absence of defecation, frequency, time of defecation, quantity, property, color, feeling of incomplete evacuation, abdominal pain, odor) 2. Gut microbiota 3. Gut metabolomes 4. Abdominal symptoms (bloating, belching, gas(flatus frequency)) at times other than during defecation 5. RPE 6. POMS2 Japanese version, Short Form 7. Blood biochemical parameters (CK, GLU, Lactic acid, Free fatty acids)

Countries

Japan

Contacts

Public ContactFumiko Nakamura

CPCC Company Limited Clinical Support Division

cpcc-contact@cpcc.co.jp+81-3-6225-9001

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026